Axsome Therapeutics Files 8-K Report
Ticker: AXSM · Form: 8-K · Filed: Mar 25, 2025 · CIK: 1579428
| Field | Detail |
|---|---|
| Company | Axsome Therapeutics, INC. (AXSM) |
| Form Type | 8-K |
| Filed Date | Mar 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
Related Tickers: AXSM
TL;DR
AXSM filed an 8-K, likely with operational/financial updates. Keep an eye out.
AI Summary
On March 25, 2025, Axsome Therapeutics, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's operations and financial status. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing signals that Axsome Therapeutics is providing updated information to the SEC, which could include important operational or financial disclosures relevant to investors.
Risk Assessment
Risk Level: low — The provided excerpt is a standard SEC filing notification without specific material events or financial data that would indicate immediate risk.
Key Players & Entities
- Axsome Therapeutics, Inc. (company) — Registrant
- March 25, 2025 (date) — Date of Report
FAQ
What specific "Other Events" are being reported by Axsome Therapeutics in this 8-K filing?
The provided excerpt does not detail the specific "Other Events" being reported; it only lists the item category.
What "Financial Statements and Exhibits" are included in this 8-K filing?
The excerpt indicates that "Financial Statements and Exhibits" are part of the filing, but does not list their specific contents.
What is the filing date for this 8-K report?
The filing date for this 8-K report is March 25, 2025.
What is Axsome Therapeutics, Inc.'s principal executive office address?
Axsome Therapeutics, Inc.'s principal executive office is located at One World Trade Center, 22nd Floor, New York, New York, 10007.
What is the Commission File Number for Axsome Therapeutics, Inc.?
The Commission File Number for Axsome Therapeutics, Inc. is 001-37635.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 25, 2025 regarding Axsome Therapeutics, Inc. (AXSM).